Incyte to Buy Vega Therapeutics For Up to $2 Billion
(feeds.content.dowjones.io)
1.
2.
Plans Accelerated for Human Trials of Tooth Regeneration
(futurism.com)
3.
Chicken or the Egg? Why We Need to Rethink Data and Funding in Startups
(feeds.feedburner.com)
4.
5.
6.
Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion
(feeds.content.dowjones.io)
7.
The most innovative biotech companies of 2026
(feeds.feedburner.com)
8.
Novocure Gets FDA Approval for Pancreatic Cancer Treatment; Shares Soar
(feeds.content.dowjones.io)
9.
Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products
(feeds.content.dowjones.io)